.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval

SWASTHFIT SUPER 4

LIVER & KIDNEY PANEL, SERUM

ep
Creatinine 1.00 mg/dL 0.70 - 1.30
(Modified Jaffe,Kinetic)
GFR Estimated 107 mL/min/1.73m2 >59
(CKD EPI Equation 2021)
GFR Category G1
(KDIGO Guideline 2012)
Urea
(Urease UV)
R 40.00 mg/dL 13.00 - 43.00

Urea Nitrogen Blood 18.68 mg/dL 6.00 - 20.00

(Calculated)
BUN/Creatinine Ratio 19
(Calculated)
e
Uric Acid 7.00 mg/dL 3.50 - 7.20
(Uricase)
pl

AST (SGOT) 30.0 U/L 15.00 - 40.00

(IFCC without P5P)
ALT (SGPT) 40.0 U/L 10.00 - 49.00
(IFCC without P5P)
GGTP 50.0 U/L 0 - 73
(IFCC)
m

Alkaline Phosphatase (ALP) 100.00 U/L 30.00 - 120.00

(IFCC-AMP)
Bilirubin Total 1.00 mg/dL 0.30 - 1.20
(Oxidation)
Bilirubin Direct 0.20 mg/dL <0.3
Sa

(Oxidation)
Bilirubin Indirect 0.80 mg/dL <1.10
(Calculated)
Total Protein 8.00 g/dL 5.70 - 8.20
(Biuret)
Albumin 4.00 g/dL 3.20 - 4.80
(BCG)
A : G Ratio 1.00 0.90 - 2.00
(Calculated)
Globulin(Calculated) 4.00 gm/dL 2.0 - 3.5

Calcium, Total 9.00 mg/dL 8.70 - 10.40

(Arsenazo III)

*WM17SPF* Page 1 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval
Phosphorus 4.00 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 140.00 mEq/L 136.00 - 145.00
(Indirect ISE)

ep
Potassium 4.00 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 100.00 mEq/L 98.00 - 107.00
(Indirect ISE)

LIPID SCREEN, SERUM

Cholesterol, Total
R 100.00 mg/dL <200.00
(CHO-POD)
Triglycerides 100.00 mg/dL <150.00
(GPO-POD)
HDL Cholesterol 30.00 mg/dL >40.00
e
(Enz Immunoinhibition)
LDL Cholesterol, Calculated 50.00 mg/dL <100.00
(Calculated)
pl

VLDL Cholesterol,Calculated 20.00 mg/dL <30.00

(Calculated)
Non-HDL Cholesterol 70 mg/dL <130
(Calculated)

Note
m

1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.
Sa

Treatment Goals as per Lipid Association of India 2020

--------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL|
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)|
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | <50 | <80 | | |
| Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Extreme | | | | |
| Risk Group | ≤30 | ≤60 | >30 | >60 |
| Category A | | | | |
|------------|--------------------|--------------------|----------------|--------------------|
| Very | <50 | <80 | ≥50 | ≥80 |
| High | | | | |

*WM17SPF* Page 2 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval
|------------|--------------------|--------------------|----------------|--------------------|
| High | <70 | <100 | ≥70 | ≥100 |
|------------|--------------------|--------------------|----------------|--------------------|
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------|--------------------|--------------------|----------------|--------------------|
| Low | <100 | <130 | ≥130* | ≥160* |

ep
--------------------------------------------------------------------------------------------
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

GLUCOSE, FASTING (F)

Glucose Fasting 80.00 mg/dL 70 - 100

(Hexokinase)
R
VITAMIN B12; CYANOCOBALAMIN
(CLIA)

Vitamin B12; Cyanocobalamin 400.00 pg/mL 211.00 - 911.00

e
VITAMIN D, 25 - HYDROXY, SERUM
pl

(CLIA)

Vitamin D, 25 Hydroxy 150.00 nmol/L 75.00 - 250.00

Interpretation
m

--------------------------------------------------------------------------------------------
| LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS |
|---------------|--------------------------|-------------------------------------------------|
| Deficient | < 50 | High risk for developing bone disease |
|---------------|--------------------------|-------------------------------------------------|
| Insufficient | 50-74 | Vitamin D concentration which normalizes |
Sa

| | | Parathyroid hormone concentration |

|---------------|--------------------------|-------------------------------------------------|
| Sufficient | 75-250 | Optimal concentration for maximal health benefit|
|---------------|--------------------------|-------------------------------------------------|
| Potential | >250 | High risk for toxic effects |
| intoxication | | |
--------------------------------------------------------------------------------------------
Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.

*WM17SPF* Page 3 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available

ep
THYROID PROFILE,TOTAL, SERUM
(CLIA)

T3, Total R 1.00 ng/mL 0.60 - 1.81

T4, Total 7.00 µg/dL 5.01 - 12.45

TSH 3.00 µIU/mL 0.550 - 4.780

Note
e
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
pl

2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0.03 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
m

some individuals
Sa

*WM17SPF* Page 4 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, National Reference laboratory, Block E,
Sector 18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval
HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

ep
HbA1c 10.0 % 4.00 - 5.60

Estimated average glucose (eAG) 240 mg/dL

Interpretation
HbA1c result is suggestive of Diabetes/ Higher than glycemic goal in a known Diabetic patient.
R
Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy,
comorbid conditions, known CVD or advanced microvascular complications, hypoglycaemia unawareness,
and individual patient considerations

Interpretation as per American Diabetes Association (ADA) Guidelines

e
------------------------------------------------------------------------------------------
| Reference Group | Non diabetic | At risk | Diagnosing | Therapeutic goals |
pl

| | adults >=18 years | (Prediabetes) | Diabetes | for glycemic control |

| ----------------|-------------------|---------------|-------------|----------------------|
| HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0 |
------------------------------------------------------------------------------------------

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
m

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
Sa

| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |

| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*WM17SPF* Page 5 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval

COMPLETE BLOOD COUNT; CBC

Hemoglobin 15.00 g/dL 13.00 - 17.00

ep
(Photometry)
Packed Cell Volume (PCV) 45.00 % 40.00 - 50.00
(Calculated)
RBC Count 5.00 mill/mm3 4.50 - 5.50
(Electrical Impedence)
MCV 100.00 fL 83.00 - 101.00
(Electrical Impedence)
MCH
R 30.00 pg 27.00 - 32.00
(Calculated)
MCHC 33.00 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 12.00 % 11.60 - 14.00
e
(Electrical Impedence)
Total Leukocyte Count (TLC) 5.00 thou/mm3 4.00 - 10.00
(Electrical Impedence)
pl

Differential Leucocyte Count (DLC)

(VCS Technology)
Segmented Neutrophils 50.00 % 40.00 - 80.00
Lymphocytes 40.00 % 20.00 - 40.00
Monocytes 5.00 % 2.00 - 10.00
m

Eosinophils 4.00 % 1.00 - 6.00

Basophils 1.00 % <2.00
Absolute Leucocyte Count
(Calculated)
Sa

Neutrophils 2.50 thou/mm3 2.00 - 7.00

Lymphocytes 2.00 thou/mm3 1.00 - 3.00
Monocytes 0.25 thou/mm3 0.20 - 1.00
Eosinophils 0.20 thou/mm3 0.02 - 0.50
Basophils 0.05 thou/mm3 0.02 - 0.10
Platelet Count 151 thou/mm3 150.00 - 410.00
(Electrical impedence)
Mean Platelet Volume 6.5 fL 6.5 - 12.0
(Electrical Impedence)
Note
1. As per the recommendation of International council for Standardization in Hematology, the differential

*WM17SPF* Page 6 of 7
.

Name : Mr. DUMMY

Lab No. : WM17SPF Age : 25 Years
Ref By : SELF Gender : Male
Collected : 7/11/2023 11:08:00AM Reported : 17/1/2024 10:55:48AM
A/c Status : P Report Status : Revised
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) Processed at : LPL-NATIONAL REFERENCE LAB
National Reference laboratory, Block E, Sector National Reference laboratory, Block E,
18, ROHINI Sector 18, Rohini, New Delhi -110085
DELHI 110085

t
Test Report

or
Test Name Results Units Bio. Ref. Interval
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood

ep
Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal
MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Sr. Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- NRL - Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
R
NRL - Dr Lal PathLabs Ltd

Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda

e
MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Sr. Consultant Pathologist -
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Hematology & Immunology
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd
pl

This is a revised report & supersedes all the previously issued reports

AHEEEHAPMCIOAAMGABHMKINKAHPEFLFCNKKOAFPCJGCJOPAHEEEHA
BNFFFNBPAOFOFGEOACFDEDFHAHFHACEHMGIOEOJPMDAPNPBNFFFNB
GPFAACFPJNFNMACOFODKIGJOGABFDCIGKFPCBNFBOKKKMLECFGHOL
CJPHPNFBFNNAMGCGEAKLJLPGMPHELLIIKNGOFNMFOMCHFKNAFGFCG
OCPAHJFPNIBLHBDOGNKCFCIMCGHDCJKAOCNIBKOIKEDGHKFPGKPCH
HGNCLKFMEIMKBPEBALFCKKEGBGDDKECNOONFCCGJMLAAEMFEBIPKO
m

ICMCAHFHAFIKOJLMNCIPCKLIAHFHAKBEMLNCAKFFOKKFAHFHAKHHK
FGKPCDFGABGGDAGDHAPAHJPCGFEBFLBJPCECBNFFOBDGCCCFBHDDL
CFAGDIFKGPJLKMLNAMKAFPPDFEFFPHCDKKNKBMMBKNCIBACDIFHOC
MJDBGAFJKBJKNKMPBALJCFLDIPLCFHKHPFHNBDGPJNDPKBOIIEHCP
FMKBNJFMBIEAOIHLOIGDJEOKPLIFFNLHKFNCBIMNNKDOLFGIKKNNL
MNNFNNEHCEIPKKEAEMGAOKIDAHFHAFKHMKFGHLNPONKIAHFHACPPL
APBBBPAPBALONHHCOOIJFIELBCHDACAJOGMIBNNBOLCBCHHCFABAJ
HHHHHHHPHPHHHPHHPPHPPHPHHHPHPHHHPPPPHPPHPHHHPHPPHPHPP
Sa

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.

*WM17SPF* Page 7 of 7